Marta Príncep
@martaprincep
INNOVATION | ENTREPRENEURSHIP | LIFE SCIENCES
ID: 828960103994949633
07-02-2017 13:34:24
360 Tweet
253 Followers
82 Following
📅 Demà dijous Alfons Carnicero parlarà de la spin-off ABLE Human Motion i del seu impacte social al #CREB Universitat Politècnica de Catalunya (UPC). Si t’interessa, vine a la planta 4 de l’ETSEIB dijous 13/12 a les 12:00 h 🕛
Excited to announce our influential #ambassadors who joined The Collider to help us grow and bring disruptive technologies to the market. Thank you all for coming today! Mobile World Capital Barcelona @bcntechcity Discover who they are: bit.ly/2RX7io7
Deja de decir que es muy difícil. Sí, de acuerdo, puede que tu idea sea una tontería. Pero puede que sea también todo lo contrario. 👉🏼 Si quieres convertirte en emprendedor, rodéate de emprendedores Ciencia Emprende
We would like to welcome Rosa Maria Abadie to ZYMVOL! Rosa will join the ZYMVOL team as Head of Legal. She is the IP&IT Director at BELLAVISTA , and she will be in charge of the company's legal matters.
Oncoheroes Biosciences is excited to announce the first investment from Dreamers Startup Ventures. Another endorsement for our unprecedented effort for advancing #newtherapies for #childhoodcancer. Learn more at oncoheroes.com/press-releases…
The #biotech #innovation sector is full new initiatives to cope with #COVID19. In BHV Partners we are working to boost the growth of the #healthtech #startups. R+D+i are key to our future. Xavier Ferràs bit.ly/2R0sWJJ #venturebuilders
3 horas • hace 3 horas Our invested company, "The Phoenix" Biel 🐦🔥 Glasses, also in Expansión! #venturebuilders #Innovations #HealthTech
Our advisors network is growing with great professionals. We warmly welcome lucianolossendiere diere, Pascal Nizet 🍀 Pascal Nizet, and Dr. Lluís Donoso-Bach
Good NEWS! Oncoheroes Biosciences' drug discovery project (2HIT Medulloblastoma), led by Eva Mendez, has been awarded the best childhood research project by Fundació Agrupació. Learn more about this project at oncoheroes.com/2hit #rarediseases #childhoodcancer #drugdiscovery
Adan Medical anAPPhylaxis is in a 375.000€ investment round, prior to launching AllergoCase, system for the prevention of serious allergic reactions, that will help managing the crisis that may suffer up to 3,6% of the population. #healthtech #innovation #venturebuilders